These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28287351)

  • 1. Zoledronic Acid Treatment in Primary Bone Marrow Edema Syndrome.
    Flores-Robles BJ; Sanz-Sanz J; Sanabria-Sanchinel AA; Huntley-Pascual D; Andréu Sánchez JL; Campos Esteban J; Blanco R; Merino-Argumanez C; Espinosa-Malpartida M; Ramos-Giráldez MC; Godoy-Tundidor H; Jiménez-Palop MM; Barbadillo Mateos C; Villa-Alcázar LF; Isasi CM; Mulero JB
    J Pain Palliat Care Pharmacother; 2017 Mar; 31(1):52-56. PubMed ID: 28287351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Marrow Edema Syndrome of the Foot and Ankle: Mid- to Long-Term Follow-up in 18 Patients.
    Singh D; Ferrero A; Rose B; Goldberg A; Cullen N
    Foot Ankle Spec; 2016 Jun; 9(3):218-26. PubMed ID: 26459365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study.
    McQueen F; Lloyd R; Doyle A; Robinson E; Lobo M; Exeter M; Taylor WJ; Jones P; Reid IR; Dalbeth N
    Ann Rheum Dis; 2011 Jun; 70(6):1091-4. PubMed ID: 21342915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of various treatment modalities for the management of bone marrow edema syndrome/transient osteoporosis in men and non-pregnant women: a systematic review.
    Paraskevopoulos K; Keskinis A; Vasios IS; Makiev KG; Tilkeridis K; Drosos GI; Ververidis AN
    Osteoporos Int; 2023 Feb; 34(2):269-290. PubMed ID: 36370218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial.
    Laslett LL; Doré DA; Quinn SJ; Boon P; Ryan E; Winzenberg TM; Jones G
    Ann Rheum Dis; 2012 Aug; 71(8):1322-8. PubMed ID: 22355040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Be aware of bone marrow edema syndrome in ankle arthroscopy: a case successfully treated with iloprost.
    Arazi M; Yel M; Uguz B; Emlik D
    Arthroscopy; 2006 Aug; 22(8):909.e1-3. PubMed ID: 16904599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis.
    Campbell SC; Bhoopalam N; Moritz TE; Pandya M; Iyer P; Vanveldhuizen P; Ellis NK; Thottapurathu L; Garewal H; Warren SR; Friedman N; Reda DJ
    Urology; 2010 May; 75(5):1138-43. PubMed ID: 20303574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee.
    Müller F; Appelt KA; Meier C; Suhm N
    Knee Surg Sports Traumatol Arthrosc; 2020 Feb; 28(2):408-417. PubMed ID: 31273410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture risk and zoledronic acid therapy in men with osteoporosis.
    Boonen S; Reginster JY; Kaufman JM; Lippuner K; Zanchetta J; Langdahl B; Rizzoli R; Lipschitz S; Dimai HP; Witvrouw R; Eriksen E; Brixen K; Russo L; Claessens F; Papanastasiou P; Antunez O; Su G; Bucci-Rechtweg C; Hruska J; Incera E; Vanderschueren D; Orwoll E
    N Engl J Med; 2012 Nov; 367(18):1714-23. PubMed ID: 23113482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis.
    Jarrett SJ; Conaghan PG; Sloan VS; Papanastasiou P; Ortmann CE; O'Connor PJ; Grainger AJ; Emery P
    Arthritis Rheum; 2006 May; 54(5):1410-4. PubMed ID: 16645968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of bone marrow edema syndrome in the knee with denosumab. Case report].
    Geith T; Mutschler W; Berger F
    Unfallchirurg; 2015 Mar; 118(3):230-2. PubMed ID: 25783691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission over 3 years in patients with Paget disease of bone treated with a single intravenous infusion of 5 mg zoledronic acid.
    Devogelaer JP; Geusens P; Daci E; Gielen E; Denhaerynck K; Macdonald K; Hermans C; Vancayzeele S; Abraham I; Boonen S
    Calcif Tissue Int; 2014 Mar; 94(3):311-8. PubMed ID: 24271562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Dose Therapy of Zoledronic Acid for the Treatment of Primary Bone Marrow Edema Syndrome.
    Vasiliadis AV; Zidrou C; Charitoudis G; Beletsiotis A
    Cureus; 2021 Mar; 13(3):e13977. PubMed ID: 33880304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Marrow Edema Syndrome in the Foot and Ankle.
    Mirghasemi SA; Trepman E; Sadeghi MS; Rahimi N; Rashidinia S
    Foot Ankle Int; 2016 Dec; 37(12):1364-1373. PubMed ID: 27587374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
    J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid.
    Yeh DC; Chen DR; Chao TY; Chen SC; Wang HC; Rau KM; Feng YH; Chang YC; Lee KD; Ou-Yang F; Kuo WH; Chang KJ; Lin YC; Tseng LM; Hou MF
    In Vivo; 2014; 28(5):1001-4. PubMed ID: 25189922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The painful bone marrow edema syndrome of the hip joint.
    Hofmann S
    Wien Klin Wochenschr; 2005 Feb; 117(4):111-20. PubMed ID: 15847189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
    Tunn UW; Stenzl A; Schultze-Seemann W; Strauss A; Kindler M; Miller K; Wirth MP; Zantl N; Schulze M; May C; Ruebel A; Birkholz K; Gruenwald V
    Can J Urol; 2012 Jun; 19(3):6261-7. PubMed ID: 22704310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy.
    Israeli RS; Rosenberg SJ; Saltzstein DR; Gottesman JE; Goldstein HR; Hull GW; Tran DN; Warsi GM; Lacerna LV
    Clin Genitourin Cancer; 2007 Mar; 5(4):271-7. PubMed ID: 17553207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.